Willis Investment Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.6M | Sell |
14,777
-6,149
| -29% | -$6.23M | 0.74% | 55 |
|
|
2025
Q4 | $22.5M | Buy |
20,926
+1,156
| +6% | +$1.11M | 1.16% | 33 |
|
|
2025
Q3 | $15.1M | Buy |
19,770
+10,314
| +109% | +$7.68M | 0.83% | 53 |
|
|
2025
Q2 | $7.37M | Buy |
+9,456
| New | +$7.35M | 0.43% | 68 |
|
|
2022
Q4 | – | Sell |
-9,116
| Closed | -$2.95M | – | 116 |
|
|
2022
Q3 | $2.95M | Sell |
9,116
-1,100
| -11% | -$349K | 0.21% | 80 |
|
|
2022
Q2 | $3.31M | Sell |
10,216
-39,800
| -80% | -$11.9M | 0.2% | 82 |
|
|
2022
Q1 | $14.3M | Sell |
50,016
-1,181
| -2% | -$304K | 0.76% | 56 |
|
|
2021
Q4 | $14.1M | Sell |
51,197
-814
| -2% | -$206K | 0.74% | 56 |
|
|
2021
Q3 | $12M | Sell |
52,011
-62,100
| -54% | -$15.3M | 0.69% | 58 |
|
|
2021
Q2 | $26.2M | Sell |
114,111
-29,800
| -21% | -$5.99M | 1.55% | 23 |
|
|
2021
Q1 | $26.9M | Sell |
143,911
-16,100
| -10% | -$3.15M | 1.63% | 22 |
|
|
2020
Q4 | $27M | Buy |
+160,011
| New | +$23.9M | 1.85% | 20 |
|
|
2020
Q3 | – | Sell |
-12,411
| Closed | -$2.04M | – | 108 |
|
|
2020
Q2 | $2.04M | Sell |
12,411
-20
| -0.2% | -$3.07K | 0.16% | 95 |
|
|
2020
Q1 | $1.72M | Sell |
12,431
-194,080
| -94% | -$26.7M | 0.14% | 92 |
|
|
2019
Q4 | $27.1M | Sell |
206,511
-41,500
| -17% | -$4.81M | 1.76% | 26 |
|
|
2019
Q3 | $27.7M | Buy |
248,011
+116,090
| +88% | +$12.9M | 1.86% | 14 |
|
|
2019
Q2 | $14.6M | Buy |
+131,921
| New | +$15.5M | 0.99% | 50 |
|
|
2018
Q3 | – | Sell |
-226,011
| Closed | -$19.3M | – | 113 |
|
|
2018
Q2 | $19.3M | Sell |
226,011
-19,970
| -8% | -$1.64M | 1.42% | 21 |
|
|
2018
Q1 | $19M | Buy |
245,981
+14,400
| +6% | +$1.16M | 1.47% | 22 |
|
|
2017
Q4 | $19.6M | Sell |
231,581
-32,169
| -12% | -$2.74M | 1.37% | 23 |
|
|
2017
Q3 | $22.6M | Buy |
263,750
+6,800
| +3% | +$558K | 1.63% | 10 |
|
|
2017
Q2 | $21.1M | Buy |
256,950
+750
| +0.3% | +$61.2K | 1.6% | 10 |
|
|
2017
Q1 | $21.5M | Sell |
256,200
-55,600
| -18% | -$4.45M | 1.62% | 12 |
|
|
2016
Q4 | $22.9M | Buy |
311,800
+68,800
| +28% | +$5.12M | 1.71% | 9 |
|
|
2016
Q3 | $19.5M | Sell |
243,000
-8,700
| -3% | -$696K | 1.56% | 11 |
|
|
2016
Q2 | $19.8M | Buy |
251,700
+21,000
| +9% | +$1.58M | 1.69% | 11 |
|
|
2016
Q1 | $16.6M | Buy |
230,700
+22,700
| +11% | +$1.72M | 1.46% | 19 |
|
|
2015
Q4 | $17.5M | Buy |
208,000
+6,700
| +3% | +$556K | 1.59% | 11 |
|
|
2015
Q3 | $16.8M | Buy |
201,300
+300
| +0.1% | +$25.3K | 1.65% | 11 |
|
|
2015
Q2 | $16.8M | Sell |
201,000
-43,400
| -18% | -$3.31M | 1.59% | 9 |
|
|
2015
Q1 | $17.8M | Sell |
244,400
-400
| -0.2% | -$28.5K | 1.65% | 11 |
|
|
2014
Q4 | $16.9M | Sell |
244,800
-14,100
| -5% | -$952K | 1.58% | 13 |
|
|
2014
Q3 | $16.8M | Sell |
258,900
-16,800
| -6% | -$1.06M | 1.77% | 11 |
|
|
2014
Q2 | $17.1M | Sell |
275,700
-16,470
| -6% | -$983K | 1.67% | 12 |
|
|
2014
Q1 | $17.2M | Sell |
292,170
-2,300
| -0.8% | -$128K | 1.74% | 11 |
|
|
2013
Q4 | $15K | Buy |
294,470
+55,800
| +23% | +$2.79M | 0.7% | 23 |
|
|
2013
Q3 | $11.7M | Hold |
238,670
| – | – | 1.34% | 33 |
|
|
2013
Q2 | $11.7M | Buy |
+238,670
| New | +$13M | 1.34% | 33 |
|
Other funds holding LLY
VCM
VPM
Willis Investment Counsel's LLY Position: Q1 2026 in Review
Willis Investment Counsel reduced its Eli Lilly (LLY) stake by 29% in Q1 2026, selling an estimated $6.23M and leaving 14,777 shares worth $13.6M. The position accounts for 0.74% of the portfolio, ranked #55.
Willis Investment Counsel first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $27.7M in Q3 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Willis Investment Counsel held 14,777 shares of Eli Lilly worth $13.6M as of Q1 2026.
- Willis Investment Counsel sold 6,149 Eli Lilly shares in Q1 2026, an estimated $6.23M.
- Eli Lilly made up 0.74% of Willis Investment Counsel's portfolio in Q1 2026, its #55 holding.
- Willis Investment Counsel first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Willis Investment Counsel's Eli Lilly position peaked at $27.7M in Q3 2019.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Willis Investment Counsel's 13F filing for Q1 2026, filed 5 May 2026.